Margaret Lashof-sullivan

Title: Innovations in Drug Delivery: The Contributions of Margaret Lashof-Sullivan

Introduction

Margaret Lashof-Sullivan is an accomplished inventor based in Watertown, MA (US). She has made significant contributions to the field of drug delivery systems, particularly in the treatment of pancreatic cancer. With a total of 2 patents, her work focuses on innovative methods that enhance the efficacy of pharmaceutical treatments.

Latest Patents

Margaret's latest patents include groundbreaking methods for treating pancreatic cancer. One of her patents describes implantable and biodegradable drug delivery devices that can deliver an active pharmaceutical ingredient (API) directly to target pancreatic tumor tissue. These devices consist of at least two layers, where one layer contains the API and a biodegradable polymer, while the second layer includes another biodegradable polymer that degrades more slowly. This design allows the API layer to release the drug towards the target tissue while preventing the API from affecting non-target tissues.

Another patent by Margaret outlines similar implantable and biodegradable drug delivery devices capable of delivering an API directly to a target tissue site. The dual-layer structure ensures that the API is effectively delivered to the intended site, enhancing treatment outcomes for patients.

Career Highlights

Margaret Lashof-Sullivan is currently associated with Panther Therapeutics, Inc., where she continues to innovate in the field of drug delivery. Her work has garnered attention for its potential to improve treatment options for patients suffering from pancreatic cancer.

Collaborations

Margaret collaborates with Laura Indolfi, who is also a prominent figure in the field. Their partnership exemplifies the importance of teamwork in advancing medical technologies.

Conclusion

Margaret Lashof-Sullivan's contributions to drug delivery systems represent a significant advancement in the treatment of pancreatic cancer. Her innovative patents and ongoing work at Panther Therapeutics, Inc. highlight her dedication to improving patient outcomes through technology.